ULTRASONIC ELECTRONIC RHINITIS THERAPEUTIC APPARATUS WITH FAR-INFRARED ATOMIZED COCONUT ESSENTIAL OIL

Abstract

An ultrasonic electronic rhinitis therapeutic apparatus with far-infrared atomized coconut essential oil is disclosed. The apparatus includes a nasal plug part and a nasal alar part. The nasal plug part includes an insertion column disposed in a nostril. The insertion column is internally provided with a coconut powder, and a far-infrared generating tube is arranged in the coconut powder. An ultrasonic generator is arranged in the nasal alar part, and the nasal alar part is fitted on the lateral side of the nasal alar. In the disclosure, the oil and acid substance in the coconut powder are atomized by far-infrared light and are atomized under the aid of pulse ultrasonic wave in the nasal cavity to be inhaled into the internal tissues of the nasal cavity, sinus and the like.

Claims

1. An ultrasonic electronic rhinitis therapeutic apparatus with far-infrared atomized coconut essential oil, comprising a nasal plug part and a nasal alar part; wherein the nasal plug part comprises an insertion column disposed in a nostril; the insertion column is internally provided with coconut powder; a far-infrared generating tube is provided in the coconut powder; an ultrasonic generator is provided in the nasal alar part; and the nasal alar part is fitted on a lateral side of the nasal alar.

2. The apparatus of claim 1, wherein the far-infrared generating tube is provided at the middle position of the insertion column; wherein the number of the insertion column is two and the two insertion columns are provided and arranged in two nostrils respectively.

3. The apparatus of claim 1, wherein the insertion column comprises a coconut powder sleeve; the coconut powder sleeve is a hollow cylindrical bag; the hollow cylindrical bag is filled with the coconut powder; and the far-infrared generating tube is provided at a hollow position of the hollow cylindrical bag.

4. The apparatus of claim 3, wherein a material of the hollow cylindrical bag comprises polyethylene terephthalate (PET) non-woven fabric, and is made by sealing and pressing with a sealing press, and is sleeved at the bottom of the far-infrared generating tube for packaging.

5. The apparatus of claim 1, wherein an outer surface of the far-infrared generating tube is coated with a graphene far-infrared film.

6. The apparatus of claim 5, wherein the bottom of the far-infrared generating tube is connected with a screw threaded base, and the screw thread base is provided with a circuit connection point.

7. The apparatus of claim 1, wherein the nasal alar part further comprises a connecting part; the insertion column is provided vertically on the connecting part; the nasal alar part is connected to a top end of the connecting part; two nasal alar parts are provided; and the two nasal alar parts are fitted on both sides of the outer part of the nasal alar.

8. The apparatus of claim 1, wherein the two ends of the connecting part along the lateral corresponding direction of the nostril are provided with wearing fixing holes.

9. The apparatus of claim 1, further comprising an external control circuit; wherein the external control circuit is electrically connected with the far-infrared generating tube and the ultrasonic generator, and is configured to supply power to the far-infrared generating tube and the ultrasonic generator, and perform timed counting.

10. The apparatus of claim 1, wherein the ultrasonic electronic rhinitis therapeutic apparatus is used for atomizing an atomized grease and acid of the coconut powder, and the acid comprises lauric acid.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In order to explain the embodiment of the present disclosure or the technical scheme in the prior art more clearly, the drawings used in the embodiment or the description of the prior art will be briefly introduced below. Obviously, the drawings in the following description are only embodiments of the present disclosure, and for ordinary technicians in the field, other drawings can be obtained according to the provided drawings without paying creative effort.

[0025] FIG. 1 is a structural diagram of an ultrasonic electronic rhinitis therapeutic apparatus with far-infrared atomized coconut essential oil provided by an embodiment of the present disclosure.

[0026] FIG. 2 is a structural diagram of an insertion column provided by an embodiment of the present disclosure.

[0027] FIG. 3 is a structural diagram of a hollow cylindrical bag provided by an embodiment of the present disclosure.

DETAILED DESCRIPTION OF THE EMBODIMENTS

[0028] The following will clearly and completely describe the technical scheme in the embodiments of the present disclosure with reference to the drawings in the embodiments of the present disclosure. Obviously, the described embodiments are only parts of the embodiments of the present disclosure, but not all of them. Based on the embodiments of the present disclosure, all other embodiments obtained by a person of ordinary skill in the art without creative efforts are within the scope of the present disclosure.

[0029] An ultrasonic electronic rhinitis therapeutic apparatus with far-infrared atomized coconut essential oil is disclosed, which belongs to a wearing electronic rhinitis therapeutic apparatus. The apparatus includes a nasal plug part and a nasal alar part 2. The nose plug part includes an insertion column 3 disposed in a nostril. The insertion column 3 is internally provided with a coconut powder. A far-infrared generating tube 4 is provided in the coconut powder. An ultrasonic generator is arranged in the nasal alar part 2, and the nasal alar part 2 is fitted on the lateral side of the nose alar. The far-infrared generating tube 4 is inserted into a medicine bag with coconut powder, and the nasal alar part 2 encapsulates low intensity pulsed ultrasound (LIPUS).

[0030] In one embodiment, the ultrasonic electronic rhinitis therapeutic apparatus is used for atomizing a grease and acid of coconut powder. By atomizing the grease and acid (mainly lauric acid) in the coconut powder into nasal sinus energy internal tissue, a continuous, stable and low-stimulation drug supply treatment method is provided for the tissue.

[0031] This embodiment solves the following problems: 1. The disadvantage of single therapeutic effect of infrared rhinitis therapeutic apparatus; 2. The disadvantage of rhinitis irrigator spray cannot be used continuously; 3. The characteristic of nasal hypersensitivity and inability to use large amounts of medication; 4. Complex nasal cavity structure and a single drug cannot solve the problem of multi-site lesions; 5. Unable to effectively treat inflammation or enlargement problems of nasal cavity, nasal sinus and nasal polyp.

[0032] In use of this embodiment, the insertion column 3 is placed in the nostril, and then the nasal alar part 2 is fitted on the nasal alar to open the far-infrared generating tube 4. The far-infrared ray irradiates the coconut powder in the insertion column 3 and effective medicine components in the coconut powder are volatilized. At the same time, under the atomization of the ultrasonic generator, the effective medicine components are further accelerated to be atomized, and are fully diffused to various tissues in the nose along with the respiratory action, thereby keeping the retention time of the medicine in the nasal cavity and improving the treatment effect.

[0033] In one embodiment, the far-infrared generating tube 4 with the wavelength of 8-15 microns is selected. The far-infrared generating tube 4 is provided at the middle position of the insertion column 3, and the coconut powder in the insertion column 3 is more beneficial to uniformly receiving the irradiation of the far-infrared generating tube 4.

[0034] In one embodiment, the insertion column 3 includes a coconut powder sleeve in the form of a hollow cylindrical bag 5 filled with coconut powder 10. The far-infrared generating tube 4 is placed at the hollow position of the hollow cylindrical bag 5.

[0035] In the implementation of the embodiment, the update and replacement of the product can be completed by replacing the coconut powder cover, and when the current coconut pow is used up, the whole electronic rhinitis therapeutic apparatus is not required to be replaced, and only a new coconut powder sleeve is required to be replaced, so that the cost of the product is reduced, and the convenience for using and updating the product is increased.

[0036] In one embodiment, referring to the FIG. 3, the material of the hollow cylindrical bag 5 includes a Polyethylene terephthalate (PET) non-woven fabric 50, and is made by sealing and pressing with a sealing press, and is sleeved at the bottom of the far-infrared generating tube for packaging. The bottom part is an end part inserted into a nostril.

[0037] Specifically, referring to the FIG. 3, a hollow cylindrical bag 5 is filled with coconut powder 10. The preparation processes of the powder are as follows: coconut is air-dried at low temperature and crushed to 50 meshes. The coconut powder was filled into the hollow cylindrical bag 5 (air permeability 41.21/sq.m/sec,196 Pa, thickness 0.19 mm) of PET food grade non-woven fabric. The packaging structure of the hollow cylindrical bag 5 is as follows: after the hollow cylindrical bag 5 is filled, a non-woven fabric bag 50 with a thickness of 0.25 cm and a width of 2.3 cm is used for packaging by using a sealing press and is screwed into a cylinder with a diameter of 1 cm and a length of 2.3 cm and a space with a little space. A far-infrared light generator is arranged in the middle and the bottom is packaged.

[0038] In one embodiment, the outer surface of the far-infrared generating tube 4 is coated with a graphene far-infrared film 7.

[0039] In one embodiment, the bottom of the far-infrared generating tube 4 is connected with a screw thread base 8. The screw thread base is provided with a circuit connection point.

[0040] In one embodiment, the nasal alar part 2 further includes a connecting part 1. The insertion column 3 is arranged vertically on the connecting part 1. As shown in FIG. 1, the shape of the connecting part 1 is matched to the shape of the nose front end surface. The fitting property is enhanced, and the position of the insertion column 3 corresponds to the position of the nostril of the human body.

[0041] In one embodiment, two insertion columns 3 are provided and arranged in two nostrils respectively.

[0042] In one embodiment, the coconut powder is placed in a hollow cylindrical bag 5, one end of the hollow portion of the hollow cylindrical bag 5 has an opening, the other end of the hollow cylindrical bag is closed. The far-infrared generating tube 4 is directly sheathed through the opening of the hollow cylindrical bag when in use, and a new coconut powder sleeve is replaced in each time of use.

[0043] In one embodiment, the nasal alar part 2 is connected to the top end of the connecting part 1. Two nasal alar parts are provided, and fitted on both sides of the outer part of the nasal alar. As shown in FIG. 1, the nasal alar part 2 protrudes from the top position of the connecting part 1, which corresponds to the position of the nasal alar of the human body relative to the nostril. When in use, the nasal alar part 2 is folded at an angle along the dotted line in the drawing to fit over the nasal alar.

[0044] In one embodiment, the two ends of the connecting part 1 along the lateral corresponding direction of the nostril are provided with wearing fixing holes 6, which can be used for connecting the wearing string.

[0045] In one embodiment, it further includes an external control circuit, wherein the external control circuit is electrically connected with the far-infrared generating tube 4 and the ultrasonic generator, and is used for supplying power to the far-infrared generating tube 4 and the ultrasonic generator, and performing timed counting.

[0046] According to the treatment characteristics of sinusitis, nasal polyps and other diseases, the treatment cycle is long, the medication is inconvenient, the drugs cannot be attached, and the mechanism of the nervous system is too sensitive. In accordance with an embodiment of this present disclosure, the insertion column 3 is inserted into the nostril, and the control circuit is opened at the same time. At this time, the far-red light generator heats the powder and infrared treats the nasal cavity of a patient at the same time, and the medicine heated by the infrared light can bring the heated volatile substances into various parts of nasal tissue along with the breathing of the patient's nose. Low intensity pulsed ultrasound can accelerate drug atomization and promote tissue recovery, and infrared light and lauric acid play a complementary role in the treatment. At the same time, heated drugs, good effect absorption, and the nasal mucosa and other tissues of the stimulation is small.

[0047] According to years of clinical practice, the treatment effect is remarkable, one hour is treated each time. The treatment cycle is full for 30 days, and the recurrence rate in five years is extremely low.

[0048] The ultrasonic electronic rhinitis therapeutic apparatus with far-infrared atomized coconut essential oil provided by the disclosure is described in detail above, and the principles and embodiments of the disclosure are illustrated by specific examples, the descriptions of the above embodiments are only used for helping to understand the method and the core idea of the disclosure; meanwhile, for those skilled in the art, according to the idea of the present disclosure, there may be changes in the specific embodiments and the scope of application, to sum up, the content of this specification should not be construed as limiting the present disclosure.

[0049] The above description of the disclosed embodiments enables those skilled in the art to make or use the disclosure. Many modifications to these embodiments will be